HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CBBB Self-Regulatory Program Will ‘Elevate Reputation’ Of Direct Selling Industry

Executive Summary

Similar to the National Advertising Division, the Direct Selling Self-Regulatory Council will provide a forum for competitive challenges in addition to routine monitoring of the direct-sales industry. Kelley Drye attorney John Villafranco predicts “greater self-regulatory focus on income misrepresentations and lavish lifestyle claims in the months ahead.”

You may also be interested in...

Direct Seller Perfectly Posh Ghosts Advertising Self-Regulatory Process, Gets FTC Referral

The BBB National Programs' Direct Selling Self-Regulatory Council has referred Salt Lake City, Utah-based beauty direct seller Perfect Posh, LLC to the FTC and Utah attorney general after it failed to respond to multiple inquiries over "aggressive" earnings claims.

Direct Selling Self-Regulation Group Has Questions For FTC On Another Supplement Marketer

BBB National Programs’ Direct Selling Self-Regulatory Council made multiple attempts beginning in October to ask ViaSalus for evidence substantiating weight loss claims for supplements independent sales associates sell and income claims the firm makes.

Supplements Mixed With Direct Selling A Recipe Ripe For Cooking US FTC Regulation Violations

Doesn’t take long to find health and wellness product marketers on list of direct sellers or find firms offering those products in the FTC's history of enforcement actions in the sector. 

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts